Journal of the Korean Industrial and Engineering Chemistry, Vol.20, No.6, 632-637, December, 2009
Pluronic F127을 함유하는 Poly(ε-caprolacton)/ethyl cellulose 마이크로 캡슐의 제조 및 방출 특성
Preparations and Release Property of Poly(ε-caprolacton)/ethyl cellulose Microcapsule Containing Pluronic F127
E-mail:
초록
Pluronic F127을 함유한 poly(ε-caprolacton) / ethyl cellulose (PCL/EC) 마이크로 캡슐을 분무건조법으로 제조하였다. 20% (w/v)의 pluronic F127 수용액을 수상으로, 5% (w/w)의 PCL/EC이 녹아있는 디클로로메탄(dichloromethane)을 유기상으로 이용하여 water-in-oil (W/O) 에멀젼을 제조하였고, 이를 분무건조하여 마이크로 캡슐을 얻어낼 수 있었다. 주사전자현미경과 입도분석기로 분석한 결과, 수 마이크로부터 수십 마이크로 크기의 마이크로 캡슐이 형성을 확인되었다. 시차주사열량측 정기로 마이크로 캡슐의 상전이 온도를 조사한 결과, 마이크로 캡슐 제조 시 사용된 고분자들의 상전이 온도가 관찰되었다. 마이크로 캡슐의 온도 의존적 방출 특성은 30∼45 ℃에서 관찰하였으며, 수용성 염료인 fluorescein isothiocyanate-dextran (FITC-dextran)과 blue dextran을 방출모델시약으로 하였다. 온도가 증가할수록 마이크로 캡슐로부터 방출되는 양이 증가하였으며, 방출모델시약의 분자량이 작을수록 더 많이 방출되었다.
Poly(ε-caprolacton)/ethyl cellulose (PCL/EC) microcapsules containing pluronic F127 were prepared by a spray drying method. The aqueous phase, 20% of pluronic F127 was dissolved in distilled water, and the organic phase, 5% of PCL and EC were dissolved in dichloromethane. The microcapsules were obtained by spray drying the water-in-oil (W/O) emulsion. According
to the data of scanning electron microscopy and particle analyzer, tens of micro size microcapsules were observed. On a differential scanning calorimeter, the phase transition temperatures of microcapsules were observed and they were found around those of pluronic F127 and poly(ε-caprolacton), which were the main components of the microcapsules. At the range
of 30∼45 ℃, temperature-dependent release properties were investigated using fluorescein isothicyanate-dextran (FITCdextran) and blue dextran as a model drug. When the temperature was increased, the degree of release of microcapsule was also increased. FITC-dextran, the relative low molecular weight, was more released than blue-dextran.
- Drummond DC, Zignani M, Leroux JC, Prog. Lipid Res., 39, 209 (2000)
- Hruby M, Konak C, Ulbrich K, J. Control. Release, 103, 137 (2005)
- Gupta P, Vermani K, Garg S, Drug Discov. Today, 7, 569 (2002)
- Hiraka K, Kanehisa M, Tamai M, Asayama S, Colloids Surf. B., 67, 54 (2008)
- Kono K, Nakai R, Morimoto K, Takagishi T, Biochim. Biophys. Acta, 1416, 239 (1999)
- Choi JH, Lee HY, Kim JC, Kim YC, J. Ind. Eng. Chem., 13(3), 380 (2007)
- Choi JH, Lee HY, Kim JC, J. Appl. Polym. Sci., 110(1), 117 (2008)
- Hua JD, Liu YF, Hu J, Wang QQ, Gong ZB, Guo XZ, J. Appl. Polym. Sci., 74(10), 2457 (1999)
- Escobar-Chavez JJ, Lopez-Cervantes M, Naik A, Kalia YN, Quintanar-Guerrero D, Ganern-Quintanar A, J. Pharm. Pharmaceut. Sci., 9, 339 (2006)
- Miyazaki S, Yokouchi C, Nakamura T, Hashiguchi N, Hou WM, Takada M, Chem. Pharm. Bull., 34, 1801 (1986)
- Morikawa K, Okada F, Hosokawa M, Kobayashi H, Cancer Res., 47, 37 (1987)
- Morimoto K, Takeeda T, Nakamoto Y, Morisaka K, Int. J. Pharm., 12, 147 (1982)
- Koller C, Buri P, S. T. P. Pharma., 3, 115 (1987)
- Chung HJ, Lee Y, Park TG, J. Control. Release, 127, 20 (2008)
- Shin YJ, Yang DH, Oh MH, Yoon YS, Shin JS, J. Ind. Eng. Chem., 15(2), 238 (2009)
- Kim JC, Lee HY, Kim MH, Lee HJ, Kang HY, Kim SM, Colloids Surf. B., 52, 52 (2006)
- Huh KM, Bae YH, Polymer, 40(22), 6147 (1999)
- Kim HK, Park TG, Int. J. Pharm, 229, 107 (2001)
- Jeong JC, Lee J, Cho K, J. Control. Release, 92, 249 (2003)
- Kim SY, Ha JC, Lee YM, J. Control. Release, 65, 345 (2000)
- Gunder W, Lippold BH, Lippold BC, Eur. J. Pharm. Sci., 3, 203 (1995)
- Fukumori Y, Ichikawa H, Tokumitsu H, Miyamoto M, Kono K, Kanamori R, Akineand Y, Tokita N, Chem. Pharm. Bull., 41, 1144 (1993)
- Rekhi GS, Jambhekar SS, Drug Dev. Ind. Pharm., 21, 61 (1995)
- Davis HT, Colloids Surf. A., 91, 9 (1994)
- Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK, Lim SJ, Int. J. Pharm., 226, 195 (2001)
- Raymond J, Metcalfe A, Salazkin I, Schwarz A, Biomaterials, 25, 3983 (2004)
- Newby GE, Hamley IW, King SM, Martin CM, Terrill NJ, J. Colloid Interface Sci., 329(1), 54 (2009)